The prognostic utility of 18F-FDG-PET metabolic tumor response after chemoradiotherapy for locally advanced head and neck cancer

Authors

  • Federico Ampil Department of Radiology, Louisiana State University Health and Feist-Weiller Cancer Center, Shreveport, Louisiana, USA
  • Gloria Caldito Department of Biometry, Louisiana State University Health and Feist-Weiller Cancer Center, Shreveport, Louisiana, USA
  • Carolyn Reiser Department of Nursing, Louisiana State University Health and Feist-Weiller Cancer Center, Shreveport, Louisiana, USA
  • Srinivas Devarakonda Department of Medicine, Louisiana State University Health and Feist-Weiller Cancer Center, Shreveport, Louisiana, USA
  • Amol Takalkar Department of Radiology, Louisiana State University Health and Feist-Weiller Cancer Center, Shreveport, Louisiana, USA
  • Cherie-Ann Nathan Department of Otolaryngology-Head Neck Surgery, Louisiana State University Health and Feist-Weiller Cancer Center, Shreveport, Louisiana, USA
  • Glenn Mills Department of Medicine, Louisiana State University Health and Feist-Weiller Cancer Center, Shreveport, Louisiana, USA

DOI:

https://doi.org/10.3109/0284186X.2014.987356

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2015-08-09

How to Cite

Ampil, F., Caldito, G., Reiser, C., Devarakonda, S., Takalkar, A., Nathan, C.-A., & Mills, G. (2015). The prognostic utility of 18F-FDG-PET metabolic tumor response after chemoradiotherapy for locally advanced head and neck cancer. Acta Oncologica, 54(7), 1066–1067. https://doi.org/10.3109/0284186X.2014.987356

Issue

Vol. 54 No. 7 (2015): Acta Oncologica

Section

Articles